VA
Vivek Anand
About Vivek Anand
Data last updated:
Vivek Anand is a Cfo at Premedium Pharmaceuticals Private Limited (since 2022) and Director at Indian Institute Of Translational Research Private Limited (since 2025). The companies operate in Pharma. The largest current company by reported revenue is Premedium Pharmaceuticals Private Limited at ₹9.67 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Premedium Pharmaceuticals Private Limited U24200DL2018PTC340319 | Cfo | 15 Sep 2022 | 2018 | ₹9.67 Cr (FY 2025) | Active |
 Indian Institute Of Translational Research Private Limited U72100DL2025PTC459812 | Director | 16 Dec 2025 | 2025 | Active |
Board colleagues of Vivek Anand
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Kumar | Premedium Pharmaceuticals Private Limited | Company Secretary | |
| Dilip Birdi | 08134919 | Premedium Pharmaceuticals Private Limited | Whole-Time Director |
| Sanjiv Kumar Kothari | 00760651 | Premedium Pharmaceuticals Private Limited | Director |
| Saras Malik | 08536003 | Premedium Pharmaceuticals Private Limited | Director |
| Nirmal Kumar Ganguly | 02316154 | Indian Institute Of Translational Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vivek Anand
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivek Anand
Vivek Anand currently holds 2 directorships: Premedium Pharmaceuticals Private Limited (Cfo, since 15 Sep 2022, revenue ₹9.67 Cr (FY 2025)); Indian Institute Of Translational Research Private Limited (Director, since 16 Dec 2025).
Vivek Anand was first appointed on 15 Sep 2022 as Cfo at Premedium Pharmaceuticals Private Limited. The most recent appointment on record is 16 Dec 2025 at Indian Institute Of Translational Research Private Limited.
The current boards of Vivek Anand's companies include Amit Kumar (Premedium Pharmaceuticals Private Limited), Dilip Birdi (Premedium Pharmaceuticals Private Limited), Sanjiv Kumar Kothari (Premedium Pharmaceuticals Private Limited), Saras Malik (Premedium Pharmaceuticals Private Limited), Nirmal Kumar Ganguly (Indian Institute Of Translational Research Private Limited).